In this week's Pharma Pulse, Cencora agrees to acquire American Oncology Network, five major employers back electronic prior authorization for self-funded health plans and FDA finalizes its guidance on prescription drug apps and software.
|Podcasts|September 30, 2022
Tackling Specialty Conditions and Side Effects Simultaneously
Author(s)Nicholas Saraceno, Senior Editor
Ways to combat these ailments alongside worsening mental health
Advertisement
Carol Huynh, a practicing clinical pharmacist and manager of clinical outcomes at Shields Health Solutions, a specialty pharmacy accelerator, dissects the ways to address undertreated side effects that can form as a result of having a specialty condition, including the use of an adapted care model.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Advertisement
Related to this article
In this week's Pharma Pulse, DHL adds six dedicated cold chain air corridors linking Europe and North America to Asia, Walmart rolls out a $0 prescription tier and rare disease Center of Excellence for its US workforce and FDA launches its Rare Disease Framework Initiative.
In this week's Pharma Pulse, PhRMA sues to block CMS's GLOBE pricing model, WFS opens a temperature-controlled cargo terminal in Lyon and Bayer commits $2.2 billion to a new Ohio manufacturing site.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Inside the 340B Rebate Pilot Standoff: Court, Congress, Drugmakers
2
Is Pharma Moving Too Fast on AI Agents?
3
Pharma Pulse: Cencora to Acquire AON, Amazon and Google Back ePA Expansion
4
Supply Chain Signal: PhRMA’s GLOBE Lawsuit and the New Economics of Pharma Supply Chains
5